We are proud to unveil the Mayo Clinic Berg Innovation Exchange — a major step in transforming global healthcare, made possible by the generosity of Gilchrist & Amy Berg. Learn more: mayocl.in/44FtyKN #HealthcareInnovation #MayoClinic

Sharing our work to help our CAR T-cell therapy pts, vaccine response varies by antigen: ✅ 100%: Polio & Tetanus 🟡 ~50%: Hepatitis A/B, Varicella 🔴 Only 33%: Pneumococcus 📊 Higher IgA levels = better response Read the full study → doi.org/10.1038/s41408… #CAR_T #Vaccination

In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma - The Lancet thelancet.com/journals/lance…

Inspired by her daughter, Roxana Dronca, M.D., helped create a program that brings life-saving cancer treatment directly to patients’ homes. mayocl.in/46vfxRb

Have been working w/ J Mark Sloan on this for a decade: BV-CHEP for 1L ATLL. British Journal of Haematology N=16 CR: 62.5% ORR: 87.5% mOS: 15.7m AlloSCT: 5 pts; mOS: NR Tox: cytopenias, mucositis, PN New consideration for aggressive ATLL. onlinelibrary.wiley.com/doi/epdf/10.11…

Along with collaborators at UT Southwestern Medical Center we report a study in the NEJM on the potential role of monoclonal anti-PF4 abs in recurrent miscarriage. Larger studies to follow! Mayo Clinic Mayo Clinic Labs nejm.org/doi/full/10.10…

Our Yale Cancer Center Yale University YaleHematology Yale School of Medicine most recent paper led by مؤسسة ومركز الحسين للسرطان super star resident Abdulrahman Alhajahjeh, MD evaluating Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk #AMLsm ashpublications.org/bloodadvances/…

🔥📣Excited to kick off the 34th annual Mayo Clinic Comprehensive Cancer Center Florida #Hematology/#Oncology Reviews 2025 ✅Comprehensive #CME #Practical (in-person & virtual) conference on new clinical advancements in #Hematology & #CancerCare. With AMAZING speakers from Mayo Clinic & other GREAT

Mohamed Kharfan-Dabaja, MD, MBA Razan Mohty Ricardo Parrondo, MD Carrie Thompson, MD Muhamad Alhaj Moustafa, MD, MS Vamsi Velcheti, MD MBA FASCO Shenduo Li, MD, PhD Madiha Iqbal MD Mohamed Kharfan-Dabaja, MD, MBA Hemant S. Murthy MD Erika Hamilton, MD Jeremy Jones Umair Majeed Dr. Yanyan Lou Neeta Somaiah, MD Dr. Winston Tan Adam M. Kase, MD Christina Wu Mayo Clinic Med Ed Hem-Onc Fellows Network Thor Halfdanarson

Outstanding lecture on updates of acute myeloid leukemia management in 2025 by Razan Mohty at the 34th Annual Mayo Clinic Comprehensive Cancer Center Hematology-Oncology Reviews in Amelia Island, FL Rami Manochakian MD, FASCO Cancer Education Madiha Iqbal MD Hemant S. Murthy MD

Great lecture by Dr. James Foran from Mayo Clinic Comprehensive Cancer Center in Jacksonville on updates in management of acute lymphoblastic leukemia during the 34th Mayo Clinic Annual Hematology-Oncology Reviews in Amelia Island, FL Hemant S. Murthy MD Talha Badar Rami Manochakian MD, FASCO Cancer Education Madiha Iqbal MD

Excellent update on myelodysplastic syndrome prognostication and therapeutics by Hemant S. Murthy MD at the Mayo Clinic 34th Annual Hematology-Oncology Reviews in Amelia Island, FL Rami Manochakian MD, FASCO Cancer Education Madiha Iqbal MD Mayo Clinic Comprehensive Cancer Center

Great presentation by Carrie Thompson, MD on management of low-grade non-Hodgkin lymphoma Mayo Clinic 34th Annual Hematology-Oncology Reviews in Amelia Island, FL Rami Manochakian MD, FASCO Cancer Education Madiha Iqbal MD Muhamad Alhaj Moustafa, MD, MS Hemant S. Murthy MD Mayo Clinic Comprehensive Cancer Center

Great update on management of CD30+ non-Hodgkin lymphomas by Madiha Iqbal MD at the Mayo Clinic 34th Annual Hematology-Oncology Reviews in Amelia Island, FL Mayo Clinic Comprehensive Cancer Center Rami Manochakian MD, FASCO Cancer Education Julio Chavez Muhamad Alhaj Moustafa, MD, MS Hemant S. Murthy MD

Inspiring presentation on management of aggressive non-Hodgkin lymphomas by Muhamad Alhaj Moustafa, MD, MS during the Mayo Clinic 34th Annual Hematology-Oncology Reviews in Amelia Island, FL Mayo Clinic Comprehensive Cancer Center Rami Manochakian MD, FASCO Cancer Education Madiha Iqbal MD Julio Chavez

1/ As Luciano J Costa has said so eloquently: "The only place where BCMA must come before GPRC5D is the dictionary." Talquetamab bridging before BCMA CAR-T in myeloma - short, very effective, and rapidly becoming my preferred approach for patients with aggressive #MMsm biology!

Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy astctjournal.org/article/S2666-… Mehdi Hamadani, MD Mazyar Shadman, MD MPH

🧐Rarity in hematology🧐 Blastic Plasmacytoid Dendritic Cell Neoplasm (#BPDCN) Rare but aggressive blood cancer with a name as complex as its behavior Let's break it down in an educational🧵

🎤💧

How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission ashpublications.org/blood/article-…